For the Quarter Ending December 2024
North America
The U.S. 10-Methoxy Iminostilbene market experienced a sharp decline in prices throughout Q4 2024, driven by weak demand and intense competition. During Q4 2024, the U.S. 10-Methoxy Iminostilbene market saw a consistent downward trajectory in prices. This decline was fueled by ample domestic inventories, reduced export prices, and sluggish demand from key sectors like pharmaceuticals. Aggressive pricing strategies by suppliers, especially as the holiday season neared, intensified the pressure on prices. Additionally, the market faced competition from lower-cost Chinese imports, exacerbating the oversupply situation.
Concerns over upcoming disruptions in January 2025, including potential port operation issues and proposed tariffs ranging from 10-60%, added to the cautious sentiment among buyers. Elevated inventories at major ports like Seattle and Los Angeles signaled logistical challenges, compelling businesses to rethink supply chain strategies.
While some downstream applications sustained stable demand, the export market remained subdued due to weak buyer activity and high inventories. Overall, the market reflected a pessimistic outlook for the quarter, with the ongoing destocking efforts by domestic suppliers dominating the landscape.
Asia Pacific
The 10-Methoxy Iminostilbene market in China demonstrated mixed trends, with an initial strong seller’s market transitioning to a buyer’s market by the end of the quarter. In early Q4 2024, the Chinese 10-Methoxy Iminostilbene market saw stable price increases due to robust global demand following the holiday season. Limited supply, heightened overseas inquiries, and a slowdown in feedstock shipments tightened supply chains, allowing manufacturers to raise prices and optimize profit margins.
Falling freight rates further supported international buyers, enabling bulk purchases despite higher prices. China's dominant position as the leading producer and exporter bolstered its influence, capitalizing on strong domestic and international demand. However, by late Q4, the market faced a reversal. High inventories, weak demand, and tariff threats from the incoming U.S. administration pressured suppliers to aggressively destock through discounts.
Currency manipulation exacerbated pricing instability, creating a challenging landscape for sellers. Buyers adopted a cautious approach, limiting purchases to immediate needs, which deepened the supply-demand imbalance. By the quarter's end, the market shifted to a buyer’s market, with price pressures expected to persist unless demand rebounds or production adjusts downward.
Europe
The German 10-Methoxy Iminostilbene market faced a consistent downward price trend throughout Q4 2024, driven by weak demand, surplus supply, and economic challenges in the eurozone. In October, prices began declining as favorable production conditions and excessive stock levels intensified competition.
By November, the downturn deepened, exacerbated by subdued demand, surplus inventory, and aggressive price-cutting strategies by suppliers. Limited industrial activity and cautious procurement behavior further dampened the market. The depreciation of the Euro against the dollar and muted business confidence reinforced bearish sentiment, as buyers adhered to a need-based approach.
In December, the decline persisted, with Germany’s Manufacturing PMI dropping to 42.5, signaling reduced industrial output and weaker new orders. Demand across multiple sectors remained sluggish, compelling manufacturers to adopt conservative inventory strategies. Pre-holiday stockpiling and stable downstream consumption failed to mitigate surplus supply, while limited export opportunities further pressured prices.
